| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |